SBFM — SUNSHINE BIOPHARMA INC
As of Q2 2026, 1 SEC-registered investment managers reported holding SBFM (SUNSHINE BIOPHARMA INC) in their latest 13F filings, with a combined reported value of $808 across 385 shares. That is -99.4% by share count (-61.60K shares) versus the previous quarter, while reported value moved -98.7%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
SBFM is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Renaissance Technologies history | Q3 2025 | 55.70K | $82.99K | 0.00% | Add |
| Citadel Advisors history | Q1 2026 | 46.25K | $48.10K | 0.00% | Reduce |
| Two Sigma Investments history | Q3 2025 | 21.40K | $31.89K | 0.00% | New |
| Geode Capital Management history | Q1 2024 | 20.18K | $1.22K | 0.00% | Hold |
| UBS Group AG history | Q1 2026 | 1.10K | $1.15K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 385 | $808 | 0.00% | Reduce |
| Bank of America Corp history | Q4 2025 | 5 | $6 | 0.00% | Hold |
| Citigroup Inc history | Q2 2022 | 130 | $0 | — | New |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Citadel Advisors sold 46.25K sh · $48.10K
- UBS Group AG sold 1.10K sh · $1.15K
Fund Position History — shares by quarter (top 8 funds)
| Fund | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | — | 6.87K | — | — | 26 | 26 | 26 | 1 | — | 1.00K | 1 | 7.64K | 3.83K | 3.83K | 3.83K | 14.63K | 14.63K | 385 |
| Citadel Advisors | — | — | — | — | — | — | — | 185.25K | 550.51K | — | — | — | — | 63.43K | 78.09K | 53.93K | 46.25K | — |
| Renaissance Technologies | — | — | — | — | — | — | — | 66.60K | 4.61M | — | — | — | — | 54.09K | 55.70K | — | — | — |
| Two Sigma Investments | — | — | 37.39K | — | — | — | — | — | 19.20K | — | — | — | — | — | 21.40K | — | — | — |
| Bank of America Corp | — | 3.33K | 17.02K | 13.87K | — | — | — | 10.00K | 10.00K | 100 | 34.48K | 5 | 5 | 5 | 5 | 5 | — | — |
| UBS Group AG | 2.43K | 1 | 1 | 7.21K | 2.41K | 1 | 1 | 2.20K | 1 | 1 | — | 868 | 19.89K | 206 | 206 | 1.87K | 1.10K | — |
| Citigroup Inc | — | 130 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 20.18K | 20.18K | 20.18K | 20.18K | 20.18K | 20.18K | 20.18K | 20.18K | 20.18K | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details